The “2024 Cornea Products Market Report” features a new section on the global market opportunity for Fuchs’ dystrophy treatment, examining the potential market impact of alternate Fuchs’ dystrophy treatment opportunity by region and presenting key metrics for the top 10 potential markets.
The report also includes updated estimates for population with corneal disease for six categories and 52 diseases and a revised forecast for the total population that could benefit from a cornea transplant, with breakouts for those with access to ophthalmic care and those who could benefit from upcoming therapies.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.